Cargando…

Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations

BACKGROUND: In Central and South America and Eastern and Southern Africa, Plasmodium vivax infections accounts for 71-81% and 5% of malaria cases, respectively. In these areas, chloroquine (CQ) remains the treatment of choice for P. vivax malaria. In addition, CQ has recently proven to be an effecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalil, Insaf F, Alifrangis, Michael, Recke, Camilla, Hoegberg, Lotte C, Ronn, Anita, Bygbjerg, Ib C, Koch, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170649/ https://www.ncbi.nlm.nih.gov/pubmed/21864375 http://dx.doi.org/10.1186/1475-2875-10-249

Ejemplares similares

Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum
por: Alifrangis, Michael, et al.
Publicado: (2004)

Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method
por: Enevold, Anders, et al.
Publicado: (2005)

A lactate dehydrogenase ELISA-based assay for the in vitro determination of Plasmodium berghei sensitivity to anti-malarial drugs
por: Orjuela-Sánchez, Pamela, et al.
Publicado: (2012)

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal
por: Ranjitkar, Samir, et al.
Publicado: (2011)

A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity
por: Tritten, Lucienne, et al.
Publicado: (2009)

The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics
por: A-Elbasit, Ishraga E, et al.
Publicado: (2007)

Grading fluorescein angiograms in malarial retinopathy
por: MacCormick, Ian J. C., et al.
Publicado: (2015)

Multiple Origins of Mutations in the mdr1 Gene—A Putative Marker of Chloroquine Resistance in P. vivax
por: Schousboe, Mette L., et al.
Publicado: (2015)

Occurrence of the leucine-to-phenylalanine knockdown resistance (kdr) mutation in Anopheles arabiensis populations in Tanzania, detected by a simplified high-throughput SSOP-ELISA method
por: Kulkarni, Manisha A, et al.
Publicado: (2006)

A framework for assessing the risk of resistance for anti-malarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)
por: Ringsted, Frank M, et al.
Publicado: (2011)

ELISA-based detection of gentamicin and vancomycin in protein-containing samples
por: Odekerken, Jim C. E., et al.
Publicado: (2015)

Automated and unsupervised detection of malarial parasites in microscopic images
por: Purwar, Yashasvi, et al.
Publicado: (2011)

Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009)

Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method
por: Miranda, Tiago A, et al.
Publicado: (2015)

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies
por: Corran, Patrick H, et al.
Publicado: (2008)

New molecular settings to support in vivo anti-malarial assays
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

Improved negative selection protocol for Plasmodium berghei in the rodent malarial model
por: Orr, Rachael Y, et al.
Publicado: (2012)

The ACTwatch project: methods to describe anti-malarial markets in seven countries
por: Shewchuk, Tanya, et al.
Publicado: (2011)

Quantum dots: a new tool for anti-malarial drug assays
por: Ku, Min-Je, et al.
Publicado: (2011)

Development of an ELISA-array for simultaneous detection of five encephalitis viruses
por: Kang, Xiaoping, et al.
Publicado: (2012)

Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
por: Yeo, Seon-Ju, et al.
Publicado: (2017)

A novel approach to the generation of seamless constructs for plant transformation
por: Kronbak, Remy, et al.
Publicado: (2014)

Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
por: DelleDonne, Anthony, et al.
Publicado: (2009)

Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar
por: Juliano, Jonathan J, et al.
Publicado: (2009)

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
por: Zaloumis, Sophie, et al.
Publicado: (2012)

Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay
por: Rebelo, Maria, et al.
Publicado: (2015)

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market
por: O’Connell, Kathryn A, et al.
Publicado: (2013)

Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
por: Tougan, Takahiro, et al.
Publicado: (2019)

Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions
por: Lagatie, Ole, et al.
Publicado: (2019)

In-house ELISA protocols for capsid p24 detection of diverse HIV isolates
por: Molina, Mariano A., et al.
Publicado: (2023)

Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
por: Souza Botelho, Mayra, et al.
Publicado: (2021)

Development and validation of an HILIC–MS/MS method by one-step precipitation for chloroquine in miniature pig plasma
por: Wang, Zhan-Zhang, et al.
Publicado: (2016)

COIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism data
por: Galinsky, Kevin, et al.
Publicado: (2015)

A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity
por: Men, Tran Thanh, et al.
Publicado: (2012)

Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014)

Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries
por: Mongui, Alvaro, et al.
Publicado: (2015)

Development of a TaqMan Allelic Discrimination Assay for detection of Single Nucleotides Polymorphisms associated with anti-malarial drug resistance
por: Kamau, Edwin, et al.
Publicado: (2012)

Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination
por: Bolton, Jessica S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qi2epu2i54qa8vpbhhh5k4ud6